REGISTERED
on 24 May 2022
Last Applicant/ Owned by
Suite 210
Cardiff
CA
92007
Serial Number
90419851 filed on 28th Dec 2020
Registration Number
6726144 registered on 24th May 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
VIRACTA
pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated cancers and other viral associated diseases; pharmaceutical products, namely, pharmaceutical products for treating cancer; pharmaceutical products for treating viral infections; pharmaceutical products for immune reconstitution; pharmaceutical products for cell-based immunotherapy; pharmaceutical produc Read More
Classification Information
Class [005]
Pharmaceutical Products
pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated cancers and other viral associated diseases; pharmaceutical products, namely, pharmaceutical products for treating cancer; pharmaceutical products for treating viral infections; pharmaceutical products for immune reconstitution; pharmaceutical products for cell-based immunotherapy; pharmaceutical products for T-cell adoptive transfer; pharmaceutical products for cellular adoptive transfer; pharmaceutical preparations for the treatment of cancer, tumors, and hematological malignancies
First Use Date in General
08th May 2018
First Use Date in Commerce
08th May 2018
Mark Details
Serial Number
No 90419851
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 34547-TM1007
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 24th May 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 24th May 2022 | REGISTERED-PRINCIPAL REGISTER |
| 07th Apr 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 06th Apr 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 24th Mar 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 23rd Mar 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 23rd Mar 2022 | SOU EXTENSION 1 GRANTED |
| 23rd Mar 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 15th Mar 2022 | USE AMENDMENT FILED |
| 15th Mar 2022 | SOU EXTENSION 1 FILED |